| Other income |
Schedule
of other income
| | |
2026 | | |
2026 | | |
2025 | |
| | |
US$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| |
| Bad debt recovered | |
| 4,496 | | |
| 5,771 | | |
| - | |
| Government grant | |
| 73,231 | | |
| 94,002 | | |
| 76,962 | |
| Interest income | |
| 5,526 | | |
| 7,093 | | |
| 81,350 | |
| Service income | |
| 242,095 | | |
| 310,760 | | |
| 35,000 | |
| Reversal of expected credit loss | |
| 320,512 | | |
| 411,418 | | |
| - | |
| Investment written off | |
| 1,513,289 | | |
| 1,942,500 | | |
| - | |
| Intercompany balance written off | |
| 735,281 | | |
| 943,827 | | |
| - | |
| Net Gain on Sale of Shares | |
| 344,927 | | |
| 442,758 | | |
| - | |
| Other income | |
| 710,976 | | |
| 912,630 | | |
| 1,559,177 | |
| Other
income | |
| 3,950,333 | | |
| 5,070,759 | | |
| 1,752,489 | |
Basel
Medical Group Ltd. and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
year ended June 30, 2026 and 2025
|